Joel Greenblatt's AMRX Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 22,308 shares of Amneal Pharmaceuticals, Inc. (AMRX) worth $277,288, representing 0.00% of the portfolio. First purchased in 2019-Q1, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in AMRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 47,659 shares. Largest reduction occurred in Q1 2025, reducing 35,214 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Amneal Pharmaceuticals (AMRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amneal Pharmaceuticals (AMRX) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +2,785 | Add 14.27% | 22,308 | $12.43 |
| Q4 2025 | -6,137 | Reduce 23.92% | 19,523 | $12.60 |
| Q3 2025 | -34,543 | Reduce 57.38% | 25,660 | $10.01 |
| Q2 2025 | +7,534 | Add 14.30% | 60,203 | $8.09 |
| Q1 2025 | -35,214 | Reduce 40.07% | 52,669 | $8.38 |
| Q4 2024 | +40,224 | Add 84.40% | 87,883 | $7.92 |
| Q3 2024 | +47,659 | New Buy | 47,659 | $8.32 |
| Q2 2024 | -25,322 | Sold Out | 0 | $0.00 |
| Q1 2024 | +25,322 | New Buy | 25,322 | $6.06 |
| Q4 2021 | -10,629 | Sold Out | 0 | $0.00 |
| Q3 2021 | -10,300 | Reduce 49.21% | 10,629 | $5.36 |
| Q2 2021 | +20,929 | New Buy | 20,929 | $5.11 |
| Q4 2020 | -11,503 | Sold Out | 0 | $0.00 |
| Q3 2020 | -660 | Reduce 5.43% | 11,503 | $3.91 |
| Q2 2020 | -1,213 | Reduce 9.07% | 12,163 | $4.77 |
| Q1 2020 | -1,102 | Reduce 7.61% | 13,376 | $3.51 |
| Q4 2019 | +14,478 | New Buy | 14,478 | $4.83 |
| Q3 2019 | -30,883 | Sold Out | 0 | $0.00 |
| Q2 2019 | -18,631 | Reduce 37.63% | 30,883 | $7.16 |
| Q1 2019 | +49,514 | New Buy | 49,514 | $14.18 |
Joel Greenblatt's Amneal Pharmaceuticals Investment FAQs
Joel Greenblatt first purchased Amneal Pharmaceuticals, Inc. (AMRX) in Q1 2019, acquiring 49,514 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Amneal Pharmaceuticals, Inc. (AMRX) for 20 quarters since Q1 2019.
Joel Greenblatt's largest addition to Amneal Pharmaceuticals, Inc. (AMRX) was in Q1 2019, adding 49,514 shares worth $702,000.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 22,308 shares of Amneal Pharmaceuticals, Inc. (AMRX), valued at approximately $277,288.
As of the Q1 2026 filing, Amneal Pharmaceuticals, Inc. (AMRX) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Amneal Pharmaceuticals, Inc. (AMRX) was 87,883 shares, as reported at the end of Q4 2024.